TSND-201 for the Treatment for PTSD: Functional and Global Improvements from the Open-Label Portion of the IMPACT-1 Study (T36)

Summary of poster presentation: TSND-201 provided meaningful improvements on functioning and global measures of change. Overall and across each domain of the Sheehan Disability Scale (SDS), TSND-201 demonstrated rapid and robust improvements in functioning. Improvement in functioning was consistent with the clinician-rated global improvements. View Poster

The release as fetched from its publisher. transcendtherapeutics.com ↗